Apparently, the relative cytotoxicities of Nb1 and Nb2 CAR T towards cells with low BCMA levels (Fig. 6f) were considerably reversed compared to killing of MM cell lines (Fig. 6a). The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.